FASEB J. Avanti Polar Lipids
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.06-7111com.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
fj.06-7111comv1
21/2/596    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clough, R. L.
Right arrow Articles by Stefanis, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clough, R. L.
Right arrow Articles by Stefanis, L.
(The FASEB Journal. 2007;21:596-607.)
© 2007 FASEB

A novel pathway for transcriptional regulation of {alpha}-synuclein

R. Lee Clough and Leonidas Stefanis1

Division of Basic Neurosciences, Foundation for Biomedical Research of the Academy of Athens (IIBEAA), Athens, Greece

1Correspondence: Division of Basic Neurosciences, Foundation for Biomedical Research of the Academy of Athens (IIBEAA), 11527 Athens, Greece. E-mail: lstefanis{at}bioacademy.gr

{alpha}-Synuclein is an abundant neuronal protein that has been linked to both normal synaptic function and neurodegeneration—in particular, Parkinson’s disease (PD). Uncovering mechanisms that control {alpha}-synuclein transcription is therefore critical for PD pathogenesis and synaptic function. We previously reported that in PC12 cells and primary neurons, {alpha}-synuclein is transcriptionally up-regulated after application of growth factors. In the current work we have characterized the pathway involved in this regulation in PC12 cells. The MAP/ERK pathway, and in particular Ras, is both sufficient and necessary for the NGF and basic fibroblast growth factor (bFGF) -mediated response. Significantly, response elements for this pathway, including a putative occult promoter, lie within intron 1, a hitherto unappreciated regulatory region of the gene that may be utilized in this or other settings. The PI3 kinase pathway is also involved in {alpha}-synuclein regulation, but response elements for this pathway appear to lie primarily outside of intron 1. These findings indicate that NGF- and bFGF-mediated signal transduction via the MAP/ERK and PI3 kinase pathways, and in part via regulatory regions within intron 1, may be involved in {alpha}-synuclein transcriptional regulation. Targeting of these pathways may serve to modulate {alpha}-synuclein so that it achieves desirable levels within neuronal cells.—Clough, R. L., Stefanis, L. A novel pathway for transcriptional regulation of {alpha}-synuclein.


Key Words: Parkinson’s disease • PC12 cells • ERK • PI3 kinase • NGF




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Vogiatzi, M. Xilouri, K. Vekrellis, and L. Stefanis
Wild Type {alpha}-Synuclein Is Degraded by Chaperone-mediated Autophagy and Macroautophagy in Neuronal Cells
J. Biol. Chem., August 29, 2008; 283(35): 23542 - 23556.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The Federation of American Societies for Experimental Biology.